About: Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2007 (uk) im April 2007 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q63199207-04D1CCDA-5393-4E5B-9FE4-26579BDE5183
publication date	2007-04-21 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q63199207-E01EB3A5-D389-4F30-9198-5822A413FE94
language of work or name	English
author name string	wds:Q63199207-019F65E4-3314-4C7D-AF99-ECDA97BA719E wds:Q63199207-24E708D1-6896-43AC-9F4C-A54AB5A3653E wds:Q63199207-29341D19-42E5-42D9-B164-003B584B668D wds:Q63199207-4922F66E-915E-4052-936B-08DA953FF2F8 wds:Q63199207-5B3BCB0E-9CA5-4F1F-B77C-12760C28358E wds:Q63199207-C6666628-56FA-41F6-AEE4-CEE6CE8D8F7B wds:Q63199207-CAD9AD4D-E0AF-43B2-8F83-87A4C5EF8011 wds:Q63199207-FFDAF091-6FA9-454A-83EE-4AA94AE99C24
OpenCitations bibliographic resource ID	wds:Q63199207-51AA3FDF-6288-433D-A960-8B10D73DAE64
OpenCitations bibliographic resource ID	https://w3id.org/oc/corpus/br/139
author name string	Keiichi Isaka Makio Shozu Hiroshi Ishikura Makiko Hirai Koji Yamazawa Fumitoshi Terauchi Atsuya Fujito Hirokata Nishi
OpenCitations bibliographic resource ID	139
rdfs:label	Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer (en) Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer (nl)
skos:prefLabel	Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer (en) Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer (nl)
name	Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer (en) Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer (nl)
title	wds:Q63199207-5339DC3E-2FA8-4CF4-A075-093685AAF22E
title	Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer (en)
page(s)	wds:Q63199207-86A35BD1-079E-48D9-B101-10C261B5E830
page(s)	1953-1958
instance of	wds:Q63199207-61389460-58FE-4046-9BD4-AE655AFA4D4B
instance of	scholarly article
main subject	wds:Q63199207-0C367093-6F95-41DF-85EE-DA1BF63B4525
main subject	endometrial cancer
PubMed ID	wds:Q63199207-CA2A9405-074B-4CAF-853E-B00574BAAF98
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17449880
PubMed ID	17449880
published in	wds:Q63199207-A102F8EF-1214-4589-B289-A687CEC18955
published in	Human Reproduction
issue	wds:Q63199207-C59909D4-3388-42B9-9BF0-851DFBFAF45A
volume	wds:Q63199207-16D33639-0D4D-47B8-9C29-E3E6A356E8A0
issue	7
volume	22
DOI	wds:Q63199207-05425356-B6D5-48E8-B44A-3E0196A85515
DOI	http://dx.doi.org/10.1093/HUMREP/DEM088
DOI	10.1093/HUMREP/DEM088
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q63199207
is cites work of	ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study. Fertility sparing treatment of complex atypical hyperplasia and low grade endometrial cancer using oral progestin. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review Critical tumor suppressor function mediated by epithelial Mig-6 in endometrial cancer The Nm23-H1 metastasis suppressor as a translational target Clinical-translational strategies for the elevation of Nm23-H1 metastasis suppressor gene expression Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature Clinical-translational approaches to the Nm23-H1 metastasis suppressor Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy Fertility-sparing treatment using medroxyprogesterone acetate for endometrial carcinoma. Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasia. Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment Preserving fertility in young patients with endometrial cancer: current perspectives Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report. Comparison of fertility-sparing treatments in patients with early endometrial cancer and atypical complex hyperplasia: A meta-analysis and systematic review Mig-6 regulates endometrial genes involved in cell cycle and progesterone signaling. Conservative treatment of early endometrial cancer: preliminary results of a pilot study Controversies in the management of endometrial carcinoma: an update Fertility preservation in reproductive age women with cancer Comparison among fertility-sparing therapies for well differentiate early-stage endometrial carcinoma and complex atypical hyperplasia Fertility-conservation combined therapy with hysteroscopic resection and oral progesterone for local early stage endometrial carcinoma in young women Mig-6 Mouse Model of Endometrial Cancer. Endometrial adenocarcinoma in a 27-year-old woman. Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma Steroid hormone intervenes in the endometrial tumorigenesis of pten ablation Conservative treatment for well-differentiated endometrial cancer: when and why it should be considered in young women Weight control is vital for patients with early-stage endometrial cancer or complex atypical hyperplasia who have received progestin therapy to spare fertility: a systematic review and meta-analysis Case report: Successful IVF programme after conservatively treated endometrial cancer.
is cites work of	wds:Q36372293-EDB46991-BBE9-413A-A521-9DD04AAA30A2 wds:Q37242266-12ABD197-927D-49C6-A8DB-36BA45A9807D wds:Q64988801-1A411E78-E6FE-4D38-B956-92CB9A2703DB wds:Q34182662-8022050D-F807-4998-9D02-B37568671A46 wds:Q33805699-D7CE4769-5DC5-4438-A345-AE82E7D96022 wds:Q35837883-FC576FB2-E056-45C5-B1F0-0E285E4FFE38 wds:Q34642487-418D6D5B-7C9A-4409-A56B-FA35E35D6F9D wds:Q36376499-9A03C3CF-AB32-4C1B-B35B-8A908B414D4B wds:Q36183292-335D2818-9758-46BF-BFD8-E82892B12E4A wds:Q37100117-4649955B-9288-4D3D-9A85-49F9C8581C67 wds:Q42090449-99B5388B-41D7-4F1B-9154-15D0098D1498 wds:Q51290637-73C3AA6F-D995-43B0-BDB2-778C83412EFC wds:Q36409970-C3A1DC01-0B58-43A8-BF0E-96FFB987BA59 wds:Q36741896-4FF1D461-C11D-499D-8E84-708AEBF04A99 wds:Q34305296-0662F5A0-0AEE-4FDB-9CC7-103A1C3779BF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software